University of Rochester

University of Rochester was paid $368.32M by Medicaid between Jan 2018 and Dec 2024, across 912 billing codes. Its largest line is 90791, psychiatric diagnostic evaluation — 5.5% of everything it billed.

33Billing provider infoUNIVERSITY OF ROCHESTER
ROCHESTER, NY 14642

33aNPI1346285657assigned 06/19/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$368.32M

24GClaims4,872,721

24DCodes billed912

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in New York

Rank by total paid#3 of 231

Median peer was paid$561K

This provider vs. median657×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	98,208	$8.79M
2019	374,014	$23.38M
2020	816,672	$52.92M
2021	984,790	$67.01M
2022	919,400	$77.38M
2023	921,271	$77.95M
2024incomplete	758,366	$60.88M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
90791	Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation	5.5%	30,256	23,617	$20.18M
90834	Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient	3.9%	96,989	59,639	$14.45M
T1040	Medicaid certified community behavioral health clinic services, per diem	3.8%	134,597	21,308	$13.82M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	3.5%	96,117	81,941	$12.77M
90832	Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient	3.2%	84,712	53,713	$11.93M
J9271	Injection, pembrolizumab, 1 mg	3.0%	1,294	1,012	$11.16M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	2.9%	56,745	53,006	$10.66M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	2.6%	71,832	62,623	$9.73M
S9485	Crisis intervention mental health services, per diem	2.5%	7,605	6,943	$9.26M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	2.4%	110,219	104,712	$8.82M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	2.4%	51,733	48,740	$8.78M
J2350	Injection, ocrelizumab, 1 mg	2.4%	358	343	$8.68M

900 more codes

H0040	Assertive community treatment program, per diem	2.2%	4,801	$8.11M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	2.2%	95,523	$7.99M
H0020	Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program)	2.1%	261,949	$7.61M
H2011	Crisis intervention service, per 15 minutes	1.4%	37,895	$5.18M
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	1.3%	4,473	$4.93M
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	1.2%	1,830	$4.58M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	1.1%	32,491	$4.23M
90837	Psychotherapy session, about an hour	1.1%	24,356	$4.02M
H0035	Mental health partial hospitalization, treatment, less than 24 hours	1.0%	16,448	$3.81M
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	24,501	$3.61M
J3380	Injection, vedolizumab, intravenous, 1 mg	<1%	1,052	$3.41M
99285	Emergency room visit (most serious)	<1%	17,053	$3.31M
H0005	Alcohol and/or drug services; group counseling by a clinician	<1%	14,833	$3.18M
41899	Unlisted procedure, dentoalveolar structures	<1%	2,904	$3.16M
96415		<1%	6,475	$3.14M
G0396	Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes	<1%	13,402	$3.13M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	17,134	$3.04M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	84,865	$2.97M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	22,774	$2.95M
99215	Doctor's office visit, returning patient (complex)	<1%	21,061	$2.94M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	83,390	$2.73M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	12,957	$2.70M
96361	Intravenous infusion, hydration; each additional hour	<1%	12,517	$2.68M
87631		<1%	25,903	$2.60M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	3,512	$2.52M
G0397	Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes	<1%	9,950	$2.41M
J2426	Injection, paliperidone palmitate extended release (invega sustenna), 1 mg	<1%	2,127	$2.30M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	805	$2.30M
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	3,217	$2.26M
70450	Computed tomography, head or brain; without contrast material	<1%	7,732	$2.11M
80053	Comprehensive metabolic panel	<1%	165,677	$2.06M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	8,653	$1.97M
D9223	Deep sedation/general anesthesia - each subsequent 15 minute increment	<1%	5,393	$1.92M
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	1,270	$1.83M
G0378	Hospital observation service, per hour	<1%	4,102	$1.81M
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	1,387	$1.80M
90853	Group psychotherapy (other than of a multiple-family group)	<1%	15,144	$1.77M
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	7,185	$1.75M
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	16,432	$1.74M
J0490	Injection, belimumab, 10 mg	<1%	732	$1.74M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	69,411	$1.70M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	4,563	$1.60M
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	6,801	$1.59M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	2,163	$1.53M
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	47,881	$1.44M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	31,652	$1.39M
97161		<1%	13,427	$1.37M
84443	Thyroid stimulating hormone (TSH)	<1%	90,755	$1.35M
80048	Basic metabolic panel (calcium, ionized)	<1%	79,247	$1.24M
90847	Family psychotherapy with the patient present, 50 minutes	<1%	5,522	$1.19M
D7210	Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth	<1%	10,628	$1.16M
52000		<1%	962	$1.12M
D7240	Removal of impacted tooth - completely bony	<1%	3,324	$1.10M
59025	Fetal non-stress test	<1%	7,627	$1.08M
80061	Lipid panel	<1%	89,332	$1.06M
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	2,542	$1.04M
64483		<1%	1,808	$1.03M
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	7,101	$1.03M
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	12,871	$984K
J2323	Injection, natalizumab, 1 mg	<1%	771	$969K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	34,895	$968K
D2930	Prefabricated stainless steel crown - primary tooth	<1%	8,101	$923K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	140,516	$893K
59841		<1%	990	$886K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	2,849	$877K
36415	Collection of venous blood by venipuncture	<1%	183,369	$874K
J1950	Injection, leuprolide acetate (for depot suspension), per 3.75 mg	<1%	429	$869K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	4,784	$867K
D7140	Extraction, erupted tooth or exposed root	<1%	8,476	$825K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	40,900	$819K
76770		<1%	6,589	$815K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	3,676	$809K
D9222		<1%	4,134	$804K
95782		<1%	1,141	$800K
H0038	Self-help/peer services, per 15 minutes	<1%	3,520	$772K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	14,519	$767K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	3,842	$761K
71275	Computed tomographic angiography, chest, with contrast material	<1%	2,315	$711K
97162		<1%	5,772	$705K
12001		<1%	1,752	$652K
64493		<1%	1,072	$646K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	2,125	$635K
D0120	Dental checkup, returning patient	<1%	15,947	$627K
T1016	Case management, each 15 minutes	<1%	3,626	$620K
87536		<1%	7,476	$591K
G0145	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision	<1%	19,124	$586K
77336		<1%	1,639	$583K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	11,333	$582K
87480		<1%	31,445	$573K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	9,756	$566K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	17,854	$565K
90846	Family psychotherapy without the patient present, 50 minutes	<1%	3,589	$565K
87510		<1%	30,956	$561K
86780		<1%	41,521	$551K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	2,537	$550K
12011		<1%	1,400	$532K
83036	Hemoglobin; glycosylated (A1C)	<1%	59,004	$530K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	12,570	$519K
64615		<1%	1,386	$511K
86803		<1%	39,333	$508K
74183		<1%	1,471	$495K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	3,562	$466K
67028	Intravitreal injection of a pharmacologic agent	<1%	2,996	$460K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	1,493	$452K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	837	$447K
36430		<1%	1,064	$442K
90378		<1%	382	$439K
93975		<1%	1,475	$439K
87660		<1%	24,250	$436K
86850		<1%	19,306	$417K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	312	$404K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	8,053	$400K
80076		<1%	33,665	$398K
H0037	Community psychiatric supportive treatment program, per diem	<1%	298	$397K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	1,372	$385K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	5,886	$382K
J0178	Injection, aflibercept, 1 mg	<1%	238	$381K
92567		<1%	6,655	$380K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	913	$371K
72141		<1%	1,226	$369K
86480		<1%	6,355	$365K
58999		<1%	761	$362K
84439		<1%	42,070	$355K
87086	Culture, bacterial; quantitative colony count, urine	<1%	48,037	$355K
73221		<1%	1,171	$351K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	834	$347K
97113		<1%	3,148	$346K
82607		<1%	24,434	$331K
70496		<1%	1,211	$325K
J1631	Injection, haloperidol decanoate, per 50 mg	<1%	3,746	$312K
92557		<1%	4,510	$305K
12002		<1%	755	$298K
J0741	Injection, cabotegravir and rilpivirine, 2mg/3mg	<1%	77	$284K
82728		<1%	23,019	$284K
D7230		<1%	906	$283K
78815	Positron emission tomography (PET) for limited area imaging	<1%	379	$281K
84403		<1%	11,792	$280K
S9484	Crisis intervention mental health services, per hour	<1%	2,899	$280K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	1,719	$276K
93320		<1%	4,684	$271K
96375	Therapeutic injection; each additional sequential IV push	<1%	9,687	$270K
86008		<1%	2,569	$270K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	5,362	$267K
83970		<1%	7,022	$267K
85027		<1%	47,713	$262K
86901		<1%	19,718	$260K
97165		<1%	2,695	$255K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	2,394	$255K
93970		<1%	907	$249K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	11,021	$249K
87340		<1%	25,415	$247K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	8,882	$246K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	1,087	$245K
87506		<1%	1,338	$243K
20553		<1%	1,164	$243K
80051		<1%	11,765	$243K
H0001	Alcohol and/or drug assessment	<1%	891	$241K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	578	$231K
95812		<1%	1,591	$230K
97164		<1%	2,354	$228K
86900		<1%	19,768	$226K
Q5111	Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg	<1%	176	$224K
71046	Radiologic examination, chest; 2 views	<1%	10,013	$222K
86360		<1%	6,102	$220K
Q3014	Telehealth originating site facility fee	<1%	2,905	$220K
92134		<1%	4,537	$219K
70491		<1%	946	$217K
20611		<1%	506	$213K
94060		<1%	2,561	$212K
97803		<1%	4,866	$211K
D0150	Comprehensive oral evaluation - new or established patient	<1%	5,449	$205K
27096		<1%	419	$203K
83880		<1%	6,429	$203K
87081		<1%	29,719	$202K
88342		<1%	2,746	$199K
82670		<1%	7,506	$199K
83655		<1%	17,038	$198K
77334		<1%	744	$197K
97010		<1%	12,765	$196K
J0185	Injection, aprepitant, 1 mg	<1%	1,644	$194K
71250		<1%	1,927	$192K
86359		<1%	5,900	$189K
93350		<1%	1,470	$188K
93971		<1%	2,249	$188K
76830	Ultrasound, transvaginal	<1%	3,903	$187K
81329		<1%	1,961	$186K
88185		<1%	1,302	$183K
J2997	Injection, alteplase recombinant, 1 mg	<1%	967	$179K
H2017	Psychosocial rehabilitation, billed per 15 minutes	<1%	1,253	$177K
20610		<1%	765	$175K
84702		<1%	12,739	$175K
87522	Neg quan hep c or qual rna	<1%	4,355	$174K
96367		<1%	1,083	$173K
D1120	Dental cleaning, child	<1%	3,465	$170K
H0004	Behavioral health counseling and therapy, per 15 minutes	<1%	723	$169K
J2680	Injection, fluphenazine decanoate, up to 25 mg	<1%	1,966	$168K
D9310		<1%	2,276	$167K
88112		<1%	2,157	$166K
87529		<1%	2,813	$164K
70486		<1%	1,143	$160K
92579		<1%	2,439	$160K
D3220	Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction	<1%	1,926	$159K
92552		<1%	2,150	$159K
97166		<1%	1,362	$158K
77386		<1%	872	$155K
88341		<1%	1,285	$154K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	2,235	$154K
93976		<1%	741	$153K
J1756	Injection, iron sucrose, 1 mg	<1%	3,339	$153K
96416		<1%	352	$152K
72156		<1%	472	$151K
92611		<1%	802	$151K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	17,817	$150K
86706		<1%	14,856	$148K
74178		<1%	1,145	$147K
86704		<1%	13,355	$147K
42830		<1%	107	$144K
87150		<1%	4,276	$143K
72197		<1%	447	$141K
29125		<1%	701	$140K
93017		<1%	2,384	$139K
93325		<1%	5,392	$139K
87505		<1%	1,319	$139K
Q9956	Injection, octafluoropropane microspheres, per ml	<1%	2,358	$138K
99401		<1%	1,397	$136K
76801		<1%	2,894	$135K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	3,614	$132K
94010		<1%	2,963	$131K
J2505	Injection, pegfilgrastim, 6 mg	<1%	68	$130K
97802		<1%	2,759	$128K
83540		<1%	22,307	$127K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	3,138	$127K
70498		<1%	600	$122K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	7,047	$118K
93308		<1%	551	$117K
83735		<1%	20,901	$116K
64405		<1%	293	$116K
77300		<1%	306	$116K
82570		<1%	26,757	$115K
88307		<1%	1,226	$115K
10060		<1%	428	$115K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	1,769	$113K
84146		<1%	5,927	$109K
87186		<1%	12,412	$109K
83001		<1%	6,159	$108K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	1,276	$108K
82746		<1%	8,649	$107K
99417	Prolong home eval add 15m	<1%	821	$106K
87158		<1%	19,368	$105K
D9420		<1%	1,225	$105K
64450		<1%	315	$103K
81420	Fetal chromosomal aneuploidy genomic sequence analysis panel	<1%	191	$103K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	8,206	$102K
85610		<1%	27,066	$102K
A0225	Ambulance service, neonatal transport, base rate, emergency transport, one way	<1%	168	$101K
83550		<1%	13,597	$101K
86762		<1%	9,857	$100K
99204	Doctor's office visit, new patient (more involved)	<1%	909	$97K
64635		<1%	172	$97K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	1,955	$96K
J2357	Injection, omalizumab, 5 mg	<1%	130	$95K
84402		<1%	4,195	$94K
82043		<1%	17,858	$94K
95886		<1%	1,810	$93K
86140		<1%	25,170	$93K
84270		<1%	4,646	$92K
76942		<1%	674	$91K
81001		<1%	31,060	$90K
92133		<1%	2,713	$90K
72125	Computed tomography, cervical spine; without contrast material	<1%	694	$89K
86708		<1%	7,892	$89K
80069		<1%	9,470	$89K
62323		<1%	186	$87K
88142		<1%	1,102	$87K
C7901	Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 30-60 minutes, provided remotely by hospital staff who are licensed to provided mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service	<1%	799	$86K
73610		<1%	5,270	$85K
96402		<1%	1,595	$84K
92556		<1%	2,265	$83K
J1602	Injection, golimumab, 1 mg, for intravenous use	<1%	63	$82K
76882		<1%	2,216	$82K
64400		<1%	138	$81K
76536		<1%	2,695	$81K
86923		<1%	1,794	$80K
90715		<1%	3,097	$80K
86235		<1%	1,859	$79K
86038		<1%	7,459	$78K
84466		<1%	6,842	$78K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	5,708	$76K
0071A		<1%	1,859	$76K
97035		<1%	5,157	$76K
0001A		<1%	2,434	$75K
82784		<1%	6,482	$74K
A9573	Injection, gadopiclenol, 1 ml	<1%	2,083	$74K
83002		<1%	4,186	$73K
A9576	Injection, gadoteridol, (prohance multipack), per ml	<1%	2,884	$70K
G0124	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician	<1%	2,534	$70K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	106	$69K
87497		<1%	1,763	$68K
70543		<1%	181	$67K
76000		<1%	483	$66K
73630		<1%	4,999	$65K
92083		<1%	2,114	$65K
83690		<1%	13,769	$64K
99152		<1%	1,806	$62K
87799		<1%	1,538	$62K
86160		<1%	4,104	$61K
73030		<1%	3,525	$58K
81025		<1%	10,468	$58K
87632		<1%	331	$57K
82105		<1%	4,046	$57K
V5264	Ear mold/insert, not disposable, any type	<1%	1,150	$57K
S9342	Home therapy; enteral nutrition via pump; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (enteral formula and nursing visits coded separately), per diem	<1%	122	$56K
93225		<1%	1,059	$56K
J0897	Injection, denosumab, 1 mg	<1%	38	$55K
80197		<1%	4,522	$55K
86355		<1%	1,557	$54K
87070		<1%	6,521	$54K
82533		<1%	3,235	$54K
83516		<1%	4,243	$54K
85652		<1%	22,702	$52K
J9312	Injection, rituximab, 10 mg	<1%	22	$52K
D2710		<1%	361	$51K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	167	$51K
L3808	Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment	<1%	204	$51K
73130		<1%	3,158	$50K
86364		<1%	5,946	$50K
92250		<1%	1,099	$50K
D1110	Prophylaxis - adult	<1%	1,242	$50K
74230		<1%	781	$50K
80050	General health panel	<1%	1,580	$50K
82150		<1%	14,215	$50K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	194	$49K
86376		<1%	3,577	$49K
84480		<1%	4,027	$49K
90686		<1%	2,218	$48K
99205	Prolong outpt/office vis	<1%	355	$48K
96411		<1%	1,327	$48K
L2280	Addition to lower extremity, molded inner boot	<1%	152	$47K
95909		<1%	667	$47K
87338		<1%	3,585	$46K
84481		<1%	3,064	$46K
72100		<1%	2,627	$46K
83993		<1%	2,603	$46K
0124A		<1%	1,091	$45K
84100		<1%	11,387	$45K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	1,424	$45K
0002A		<1%	1,504	$44K
73562		<1%	2,682	$44K
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	<1%	1,758	$44K
88304		<1%	785	$44K
86787		<1%	4,692	$43K
82565		<1%	11,654	$42K
86357		<1%	1,559	$41K
92551		<1%	710	$41K
55899		<1%	40	$41K
93922		<1%	741	$41K
D1206	Topical application of fluoride varnish	<1%	1,259	$40K
82805		<1%	1,280	$40K
D0330	Panoramic radiographic image	<1%	842	$40K
86800		<1%	3,262	$40K
96376		<1%	2,388	$40K
73700		<1%	240	$40K
0072A		<1%	944	$39K
73564		<1%	1,794	$39K
82627		<1%	1,800	$38K
86665		<1%	2,210	$38K
71045	Radiologic examination, chest; single view	<1%	1,243	$38K
74018		<1%	3,216	$38K
D9610		<1%	2,358	$38K
76819	Fetal biophysical profile; without non-stress testing	<1%	1,000	$37K
96409		<1%	763	$37K
83020		<1%	2,919	$37K
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	3,498	$37K
86225		<1%	3,118	$37K
84460		<1%	8,164	$37K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	402	$36K
84156		<1%	10,610	$36K
D1208	Topical application of fluoride, excluding varnish	<1%	875	$36K
71271		<1%	1,321	$35K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	54	$35K
99091		<1%	746	$35K
73110		<1%	2,682	$35K
86765		<1%	3,553	$35K
72082		<1%	1,626	$34K
86696		<1%	1,915	$33K
J0401	Injection, aripiprazole (abilify maintena), 1 mg	<1%	24	$33K
16020		<1%	78	$33K
J1437	Injection, ferric derisomaltose, 10 mg	<1%	56	$33K
82785		<1%	2,202	$33K
D9999	Unspecified adjunctive procedure, by report	<1%	237	$33K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	772	$33K
76870		<1%	868	$33K
84144		<1%	1,704	$33K
83520		<1%	2,494	$33K
83615		<1%	6,464	$32K
87517		<1%	827	$32K
99406		<1%	876	$32K
86618		<1%	2,951	$32K
86304		<1%	1,651	$32K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	955	$32K
72146		<1%	108	$32K
82248		<1%	7,317	$31K
G0328	Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous	<1%	2,508	$31K
D1351	Sealant - per tooth	<1%	892	$31K
86200		<1%	2,615	$31K
81511		<1%	300	$31K
31575		<1%	235	$31K
99153	Mod sedat endo service >5yrs	<1%	709	$30K
77412		<1%	105	$30K
92610		<1%	236	$30K
C7900	Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 15-29 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service	<1%	139	$30K
82977		<1%	4,639	$30K
10061		<1%	98	$30K
96401		<1%	585	$30K
64721		<1%	31	$30K
73560		<1%	2,850	$29K
86735		<1%	3,141	$29K
88321		<1%	457	$29K
73502		<1%	2,218	$29K
84153		<1%	1,766	$28K
85380		<1%	2,145	$28K
86141		<1%	2,392	$28K
95885		<1%	579	$28K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	577	$28K
82947		<1%	9,424	$28K
84207		<1%	1,077	$28K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	27	$28K
85730		<1%	5,180	$27K
73140		<1%	2,274	$27K
99442		<1%	257	$27K
J9070	Cyclophosphamide, 100 mg	<1%	81	$27K
86305		<1%	1,391	$27K
92524		<1%	187	$27K
76825		<1%	423	$26K
G0123	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision	<1%	1,038	$26K
85007		<1%	8,864	$26K
82550		<1%	4,524	$26K
73590		<1%	2,084	$26K
A9585	Injection, gadobutrol, 0.1 ml	<1%	1,061	$26K
82610		<1%	2,279	$26K
87581		<1%	750	$26K
82950		<1%	6,007	$26K
84450		<1%	5,460	$25K
86147		<1%	938	$25K
87493		<1%	770	$25K
86430		<1%	4,635	$25K
84703		<1%	4,716	$24K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	381	$24K
92582		<1%	381	$24K
97116		<1%	663	$24K
G0176	Activity therapy, such as music, dance, art or play therapies not for recreation, related to the care and treatment of patient's disabling mental health problems, per session (45 minutes or more)	<1%	164	$24K
83498		<1%	918	$24K
85014		<1%	10,403	$24K
0054A		<1%	565	$24K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	577	$23K
86769		<1%	548	$23K
97535	Self-care/home management training, each 15 minutes	<1%	319	$23K
88184		<1%	378	$23K
94729		<1%	1,450	$23K
77002		<1%	81	$23K
95911		<1%	175	$23K
91322		<1%	174	$22K
87102		<1%	2,786	$22K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	2,539	$22K
L1970	Ankle foot orthosis, plastic with ankle joint, custom fabricated	<1%	28	$22K
72157		<1%	80	$22K
92587		<1%	310	$22K
D7220		<1%	181	$21K
0012A		<1%	1,025	$21K
84134		<1%	1,679	$20K
0011A		<1%	1,183	$20K
72158		<1%	68	$20K
95910		<1%	304	$20K
76821		<1%	843	$20K
82024		<1%	548	$20K
73100		<1%	1,641	$20K
87641		<1%	732	$20K
D0272	Bitewings - two radiographic images	<1%	1,176	$20K
83525		<1%	1,828	$20K
72170		<1%	1,171	$20K
87902		<1%	76	$20K
84425		<1%	1,041	$19K
84305		<1%	1,038	$19K
81003		<1%	8,545	$19K
0004A		<1%	453	$19K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	16	$18K
58661		<1%	12	$18K
J9045	Injection, carboplatin, 50 mg	<1%	679	$18K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	1,299	$18K
86077		<1%	511	$18K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	360	$18K
L3908	Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf	<1%	349	$18K
L3913	Hand finger orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment	<1%	86	$18K
85576		<1%	551	$18K
84165		<1%	1,922	$18K
80159		<1%	1,091	$18K
88312		<1%	207	$18K
43235		<1%	26	$18K
73090		<1%	1,356	$17K
84550		<1%	4,188	$17K
20680		<1%	12	$17K
82247		<1%	4,510	$17K
87901		<1%	76	$17K
76937		<1%	98	$17K
92526		<1%	186	$17K
J9190	Injection, fluorouracil, 500 mg	<1%	1,182	$17K
77073		<1%	664	$17K
84484		<1%	2,840	$17K
85390		<1%	2,391	$16K
T1023	Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter	<1%	88	$16K
77072		<1%	910	$16K
81507		<1%	30	$16K
73080		<1%	1,009	$16K
72040		<1%	923	$16K
87535		<1%	520	$15K
G0008	Administration of influenza virus vaccine	<1%	1,289	$15K
87538		<1%	482	$15K
70487		<1%	47	$15K
87205		<1%	4,783	$15K
77063	Screening digital breast tomosynthesis, bilateral	<1%	1,127	$15K
64490		<1%	29	$14K
84520		<1%	6,967	$14K
73070		<1%	1,247	$14K
82378		<1%	906	$14K
H2014	Skills training and development, per 15 minutes	<1%	41	$14K
J9267	Injection, paclitaxel, 1 mg	<1%	485	$14K
82330		<1%	1,328	$13K
82951		<1%	1,242	$13K
76642		<1%	338	$13K
74220		<1%	518	$13K
92025		<1%	339	$13K
82040		<1%	3,592	$13K
87040		<1%	1,757	$13K
72110		<1%	511	$13K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	1,619	$13K
82626		<1%	540	$13K
29515		<1%	62	$13K
54161		<1%	13	$13K
V5266	Battery for use in hearing device	<1%	1,498	$12K
99443		<1%	120	$12K
83090		<1%	768	$12K
0051A		<1%	283	$12K
86039		<1%	1,230	$12K
76376		<1%	200	$12K
93226		<1%	203	$11K
76813		<1%	316	$11K
81508		<1%	307	$11K
86695		<1%	1,277	$11K
82103		<1%	888	$11K
85244		<1%	485	$11K
0081A		<1%	263	$11K
96417		<1%	278	$11K
0154A		<1%	265	$11K
85045		<1%	3,184	$11K
86003		<1%	681	$11K
86902		<1%	417	$11K
43762		<1%	203	$11K
0052A		<1%	254	$11K
73552		<1%	986	$11K
86709		<1%	1,016	$10K
88173		<1%	156	$10K
V5257	Hearing aid, digital, monaural, bte	<1%	12	$10K
95819		<1%	69	$10K
80164		<1%	869	$10K
85384		<1%	1,425	$10K
81002		<1%	1,192	$10K
84075		<1%	2,718	$10K
82310		<1%	2,841	$10K
88189		<1%	189	$10K
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	238	$10K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	7,593	$10K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	32	$10K
95811		<1%	12	$10K
82677		<1%	466	$9K
73718		<1%	28	$9K
99195		<1%	155	$9K
97167		<1%	70	$9K
86592		<1%	3,013	$9K
83521		<1%	712	$9K
95908		<1%	138	$9K
85245		<1%	436	$9K
D9997		<1%	159	$9K
D2330		<1%	102	$9K
0082A		<1%	199	$8K
86334		<1%	433	$8K
82088		<1%	229	$8K
70546		<1%	24	$8K
90677		<1%	130	$8K
C1769	Guide wire	<1%	438	$8K
84630		<1%	883	$8K
87449		<1%	820	$8K
76820		<1%	714	$8K
72070		<1%	515	$8K
88262		<1%	40	$8K
87906		<1%	71	$8K
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	49	$8K
64494		<1%	37	$8K
46607		<1%	14	$8K
99203	Doctor's office visit, new patient (routine)	<1%	105	$8K
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	121	$8K
84140		<1%	390	$8K
V2632	Posterior chamber intraocular lens	<1%	542	$8K
87101		<1%	1,002	$8K
84155		<1%	3,019	$7K
D0140	Limited oral evaluation - problem focused	<1%	287	$7K
82390		<1%	816	$7K
84163		<1%	547	$7K
84295		<1%	2,697	$7K
86146		<1%	278	$7K
95012		<1%	330	$7K
87900		<1%	61	$7K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	197	$7K
10005		<1%	16	$7K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	101	$7K
0064A		<1%	161	$7K
D9230	Inhalation of nitrous oxide / analgesia, anxiolysis	<1%	188	$7K
86308		<1%	1,238	$7K
95700		<1%	81	$6K
82397		<1%	439	$6K
L1960	Ankle foot orthosis, posterior solid ankle, plastic, custom fabricated	<1%	15	$6K
76827		<1%	372	$6K
86336		<1%	466	$6K
H0002	Behavioral health screening to determine eligibility for admission to treatment program	<1%	38	$6K
90480		<1%	169	$6K
83921		<1%	386	$6K
36591		<1%	134	$6K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	37	$6K
J2704	Injection, propofol, 10 mg	<1%	5,633	$6K
88313		<1%	102	$6K
64454		<1%	19	$6K
83605		<1%	962	$6K
85240		<1%	324	$6K
88300		<1%	269	$6K
D0230	Intraoral - periapical each additional radiographic image	<1%	683	$6K
95708		<1%	52	$6K
74170		<1%	36	$6K
L3002	Foot, insert, removable, molded to patient model, plastazote or equal, each	<1%	27	$6K
46601		<1%	13	$5K
92136		<1%	174	$5K
93880		<1%	51	$5K
86664		<1%	521	$5K
86593		<1%	1,317	$5K
82166		<1%	164	$5K
96127		<1%	479	$5K
90661		<1%	198	$5K
77066	Tomosynthesis, mammo	<1%	84	$5K
73000		<1%	351	$5K
80178		<1%	823	$5K
86663		<1%	511	$5K
87324		<1%	568	$5K
82374		<1%	1,878	$5K
82435		<1%	2,026	$5K
0031A		<1%	185	$5K
0083A		<1%	116	$5K
92593		<1%	53	$5K
82525		<1%	405	$5K
86481		<1%	83	$5K
85613		<1%	528	$5K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	69	$5K
80299		<1%	190	$5K
84132		<1%	1,530	$4K
84436		<1%	743	$4K
82952		<1%	1,238	$4K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	12	$4K
87206		<1%	673	$4K
77049		<1%	12	$4K
86301		<1%	238	$4K
D0999	Unspecified diagnostic procedure, by report	<1%	26	$4K
77290		<1%	12	$4K
87184		<1%	592	$4K
75561		<1%	12	$4K
86381		<1%	264	$4K
76641		<1%	75	$4K
87507		<1%	14	$4K
78264		<1%	43	$4K
D2392	Resin-based composite - two surfaces, posterior, primary or permanent	<1%	33	$4K
84478		<1%	797	$4K
64484		<1%	13	$4K
94726		<1%	51	$4K
86255		<1%	254	$4K
97537		<1%	53	$4K
84681		<1%	196	$4K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	891	$4K
86644		<1%	373	$4K
73060		<1%	239	$4K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	55	$4K
74240		<1%	72	$4K
92520		<1%	57	$4K
86317		<1%	67	$4K
0003A		<1%	88	$3K
99441		<1%	34	$3K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	153	$3K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	32	$3K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	6,043	$3K
86015		<1%	403	$3K
87593		<1%	25	$3K
93321		<1%	88	$3K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	2,481	$3K
72050		<1%	178	$3K
85018		<1%	1,435	$3K
72081		<1%	258	$3K
80074		<1%	107	$3K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	698	$3K
82104		<1%	217	$3K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	1,386	$3K
M0220	Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring	<1%	28	$3K
82340		<1%	497	$3K
J2794	Injection, risperidone (risperdal consta), 0.5 mg	<1%	48	$3K
76818		<1%	71	$3K
96377		<1%	114	$3K
0173A		<1%	70	$3K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	5,126	$3K
77001		<1%	12	$3K
73522		<1%	195	$3K
G0009	Administration of pneumococcal vaccine	<1%	201	$3K
82523		<1%	162	$3K
86999		<1%	66	$3K
92592		<1%	38	$3K
81050		<1%	928	$3K
88333		<1%	28	$3K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	26	$2K
74455		<1%	24	$2K
95912		<1%	24	$2K
84244		<1%	126	$2K
92558		<1%	76	$2K
0134A		<1%	51	$2K
20552		<1%	12	$2K
90750		<1%	14	$2K
84445		<1%	65	$2K
0053A		<1%	47	$2K
86036		<1%	205	$2K
69209		<1%	25	$2K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	361	$2K
83789		<1%	114	$2K
86677		<1%	234	$2K
83010		<1%	158	$2K
94727		<1%	114	$2K
87075		<1%	265	$2K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	37	$2K
D9920		<1%	31	$2K
74174		<1%	12	$2K
80143		<1%	409	$2K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	144	$2K
J9370	Vincristine sulfate, 1 mg	<1%	265	$2K
99493		<1%	16	$2K
D0367		<1%	12	$2K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	223	$2K
83721		<1%	585	$2K
80175		<1%	138	$2K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	5,194	$2K
92555		<1%	37	$2K
87634		<1%	30	$2K
83630		<1%	94	$2K
96368		<1%	18	$2K
J2785	Injection, regadenoson, 0.1 mg	<1%	14	$2K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	19	$2K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	5,520	$2K
73200		<1%	12	$2K
76885		<1%	74	$2K
90785		<1%	115	$1K
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	222	$1K
77263		<1%	12	$1K
82157		<1%	51	$1K
J1630	Injection, haloperidol, up to 5 mg	<1%	626	$1K
83835		<1%	88	$1K
J1170	Injection, hydromorphone, up to 4 mg	<1%	1,751	$1K
0074A		<1%	32	$1K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	46	$1K
92652		<1%	12	$1K
J1644	Injection, heparin sodium, per 1000 units	<1%	1,068	$1K
J0690	Injection, cefazolin sodium, 500 mg	<1%	1,824	$1K
86341		<1%	38	$1K
87116		<1%	110	$1K
D2391	Resin-based composite - one surface, posterior, primary or permanent	<1%	18	$1K
76775		<1%	12	$1K
D2140		<1%	13	$1K
J9206	Injection, irinotecan, 20 mg	<1%	47	$1K
E0143	Walker, folding, wheeled, adjustable or fixed height	<1%	13	$1K
J8540	Dexamethasone, oral, 0.25 mg	<1%	2,667	$1K
86617		<1%	37	$1K
90619		<1%	50	$1K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	8,047	$1K
D0220	Intraoral - periapical first radiographic image	<1%	109	$1K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	1,632	$999.38
Q9969	Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose	<1%	120	$987.06
74022		<1%	24	$979.79
84080		<1%	77	$979.20
0073A		<1%	19	$966.49
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	30	$965.86
84432		<1%	107	$960.87
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	228	$955.57
J9060	Injection, cisplatin, powder or solution, 10 mg	<1%	86	$953.07
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	380	$934.64
88311		<1%	42	$909.02
82010		<1%	129	$879.52
76512		<1%	15	$840.02
88302		<1%	14	$830.54
86645		<1%	88	$826.62
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	597	$820.65
J2270	Injection, morphine sulfate, up to 10 mg	<1%	1,095	$805.03
J2550	Injection, promethazine hcl, up to 50 mg	<1%	642	$751.59
L3040	Foot, arch support, removable, premolded, longitudinal, each	<1%	35	$732.28
82140		<1%	58	$724.08
80177		<1%	58	$719.77
L3933	Finger orthosis, without joints, may include soft interface, custom fabricated, includes fitting and adjustment	<1%	12	$715.00
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	25	$704.86
J2060	Injection, lorazepam, 2 mg	<1%	156	$696.86
L3420	Full sole and heel wedge, between sole	<1%	16	$646.79
82465		<1%	153	$624.65
74019		<1%	13	$616.40
85046		<1%	136	$612.51
80179		<1%	327	$612.47
92553		<1%	12	$601.94
J9201	Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg	<1%	26	$594.97
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	38	$583.47
82172		<1%	40	$552.68
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	397	$551.66
J0780	Injection, prochlorperazine, up to 10 mg	<1%	290	$541.05
80047		<1%	42	$537.68
84446		<1%	39	$521.64
87110		<1%	30	$509.49
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	120	$504.68
84255		<1%	24	$498.07
86063		<1%	116	$456.27
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	82	$452.43
83883		<1%	39	$410.60
J3489	Injection, zoledronic acid, 1 mg	<1%	12	$392.55
85660		<1%	80	$388.81
70355		<1%	12	$388.62
90670		<1%	21	$380.60
97012		<1%	24	$364.12
90472	Immunization administration, each additional vaccine (list separately)	<1%	63	$360.55
80165		<1%	25	$347.69
88141		<1%	12	$346.92
87045		<1%	38	$319.47
J1171	Injection, hydromorphone, 0.1 mg	<1%	115	$314.32
87046		<1%	38	$303.87
J1815	Injection, insulin, per 5 units	<1%	243	$290.28
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	25	$282.34
87640		<1%	14	$281.32
82239		<1%	45	$278.78
90662		<1%	40	$248.14
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	<1%	140	$234.72
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	41	$223.69
82077		<1%	141	$223.36
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	644	$223.08
87088		<1%	27	$216.73
73600		<1%	31	$210.61
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	43	$206.71
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	12	$206.38
84510		<1%	18	$205.68
86431		<1%	39	$202.83
C1729	Catheter, drainage	<1%	12	$197.00
90656		<1%	20	$190.76
85060		<1%	12	$189.07
73660		<1%	26	$185.27
86258		<1%	22	$176.82
87015		<1%	72	$173.78
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	215	$167.93
84482		<1%	24	$164.29
J3475	Injection, magnesium sulfate, per 500 mg	<1%	159	$135.58
82379		<1%	12	$132.84
82274		<1%	12	$130.24
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	19	$130.05
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	<1%	297	$126.81
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	212	$122.60
90734		<1%	12	$119.00
93296		<1%	13	$118.79
J7510	Prednisolone oral, per 5 mg	<1%	131	$115.47
84030		<1%	18	$108.65
C9257	Injection, bevacizumab, 0.25 mg	<1%	13	$108.64
85347		<1%	31	$107.76
84300		<1%	25	$105.20
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	1,440	$90.16
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	419	$88.78
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	13	$88.51
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	46	$81.33
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	29	$78.51
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	136	$62.09
85049		<1%	16	$61.89
J1010	Injection, methylprednisolone acetate, 1 mg	<1%	13	$58.81
Q0164	Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	259	$54.45
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	315	$49.70
J3480	Injection, potassium chloride, per 2 meq	<1%	18	$41.92
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	602	$33.97
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	52	$29.64
S0020	Injection, bupivicaine hydrochloride, 30 ml	<1%	51	$25.97
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	334	$25.93
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	<1%	56	$24.37
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	19	$16.51
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	<1%	14	$11.61
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	117	$10.71
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	<1%	14	$0.94
J7611	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg	<1%	15	$0.90
90723		0%	12	$0.00
D9995		0%	80	$0.00
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	0%	12	$0.00
E0603	Breast pump, electric (ac and/or dc), any type	0%	12	$0.00
G2212	Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes)	0%	14	$0.00
90648		0%	16	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialANOLIK, ADAM (CHIEF FINANCIAL OFFICER)

Parent organizationUNIVERSITY OF ROCHESTER

Same official

Other billing entities under ANOLIK, ADAM

Full network →

Provider	Location	Paid
University of Rochester	Rochester, NY	$38.06M
Highland Hospital of Rochester	Rochester, NY	$30.82M
University of Rochester	Rochester, NY	$5.34M
University of Rochester	Rochester, NY	$2.84M
University of Rochester	Rochester, NY	$2.54M
University of Rochester	Rochester, NY	$171K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.